Skip to main content
Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
jobs
|
about
|
my BioMed Central
Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III).
Pater C
Curr Control Trials Cardiovasc Med
2004 Aug 17,
5
:8
[
Full text
]
[
PubMed
]
[
Related articles
]
[
Cited on BioMed Central
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
by date
by relevance
all 1 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
BioMed Central articles that cite the above article:
1.
Review
Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
Pater C
Current Controlled Trials in Cardiovascular Medicine
2005,
6
:1
(3 February 2005)
[
Abstract
]
[
Full Text
]
[
PDF
]
[
PubMed
]
[
Related articles
]
You can also
check ISI Web of Science
for additional citations (subscription required)
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
by date
by relevance
all 1 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated
